Discover Arcus Biosciences' groundbreaking patent for HIF-2a inhibitors, offering innovative treatments for VHL disease and various cancers. Explore its therapeutic potential!

Incyte Corp's new patent details innovative methods for synthesizing baricitinib, a key rheumatoid arthritis treatment, enhancing pharmaceutical manufacturing processes.

Several ASX companies are conducting clinical trials, and this has become a valuable sector and an asset to the Australian ...

Chief Operating Officer to Present Key Advances at Peptide Therapeutics Summit NEW ... to Clinical Stage company in FY 2023 Phase 1/2a trial, designed to assess both healthy volunteers and ...

One thing the best natural curly hairstyles never lack is versatility and dimension. Whether you have 2A waves or 4C coils, ...

Taking cues from the runway, street style looks, and expert recommendations, we've compiled the best natural curly hairstyles ...

In a phase 1 trial, Novo Nordisk's experimental obesity drug amycretin led to up to 13% weight loss in just three months.

NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative ...

Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish drugmaker's experimental ... MBX Biosciences, which is developing peptide therapies for treating ...

In 2024, gut health has become a top priority for wellness, but SANE MD was a leader in this field long before it became a mainstream trend. Today, the company ...

Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish ... which is developing peptide therapies for treating endocrine and metabolic disorders, including ...